Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
SciSparc Ltd. ( (SPRC) ) just unveiled an announcement.
On January 8, 2026, SciSparc Ltd. signed an asset purchase agreement with Xylo Technologies Ltd. to acquire a portfolio of patents, trademarks, know-how, brand names and related intellectual property, mainly tied to the MUSE single-use endoscopic system for minimally invasive treatment of gastroesophageal reflux disease (GERD). In return, SciSparc agreed to issue Xylo ordinary shares (or, at its discretion, pre-funded warrants) equal to 19.99% of SciSparc’s outstanding share capital at closing, which is expected on March 8, 2026, subject to customary conditions and any required regulatory approvals, and the company has committed to register the resale of these securities with the U.S. SEC. In a January 12, 2026 press release, SciSparc said it plans to commercialize the acquired endoscopic and medical camera technologies immediately after closing and to replicate Xylo’s earlier licensing success in Greater China—where Xylo previously secured a $3 million upfront payment—by pursuing exclusive distribution partnerships in North America, Europe and Latin America, positioning the company to tap into a global GERD device market estimated at $2.5 billion in 2024 and projected to exceed $3 billion by 2030.
More about SciSparc Ltd.
SciSparc Ltd., listed on Nasdaq, is a clinical-stage pharmaceutical company that operates primarily through its majority-owned subsidiary NeuroThera Labs Inc. The company focuses on developing cannabinoid-based pharmaceuticals, including drug candidates SCI-110 for Tourette syndrome and Alzheimer’s disease agitation, and SCI-210 for autism spectrum disorder and status epilepticus, while also holding a controlling interest in a business selling hemp seed oil-based products on Amazon.
Average Trading Volume: 1,376,471
Technical Sentiment Signal: Sell
Current Market Cap: $4.8M
For detailed information about SPRC stock, go to TipRanks’ Stock Analysis page.